During the Society of Immunotherapy of Cancer (SITC) 2025 Annual Meeting, held November 5 – 9 at the Gaylord National Resort and Convention Center in...
New preclinical data from Verismo Therapeutics' lead clinical pipeline, SynKIR™-110, targeting mesothelin in solid tumors, were presented at the Society of Immunotherapy of Cancer...
During the Society of Immunotherapy of Cancer (SITC) 2025 Annual Meeting, held November 5 – 9 at the Gaylord National Resort and Convention Center in...
During the upcoming Society of Immunotherapy in Cancer (SITC) 2025 Annual Meeting, held November 7-9, 2025, and during the American Society of Hematology (ASH)...
During the Society of Immunotherapy of Cancer (SITC) 2025 Annual Meeting, held November 5 – 9 at the Gaylord National Resort and Convention Center in...
Recordati Rare Diseases Inc. today announced the presentation of new data related to its growing portfolio of treatments for rare hematologic disorders at the...